Home›Grant Finder›Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Sponsored by National Institutes of Health
Award
Varies — see funder site
Deadline
August 18, 2026
Geography
Open nationwide
Eligible organization types
Open to most organization types — confirm on funder site.